Please login to the form below
cost
This page shows the latest cost news and features for those working in and with pharma, biotech and healthcare.
Top biopharma CEOs sign COVID-19 vaccine safety pledge
The pledge follows concerns that the speed at which vaccines are currently being developed for COVID-19 could come with a cost – namely less rigorous safety and efficacy checks.
Latest news
-
GSK’s Ionis-partnered hepatitis B drug hits the mark in phase 2
GSK licensed GSK3228836 from Ionis last year, in a deal which saw it assume responsibility for all the development, regulatory and commercialisation costs associated with the treatment.
-
COVID-19 vaccine deals with the EU hindered by strict liability rules
The contract foresees that liabilities and financial costs are shared among the parties,” the Belgian medicines agency said in a statement about the deal reached by the European Commission with AstraZeneca
-
NICE recommends Roche’s Polivy for B-cell lymphoma
Cost-effectiveness agency approves drug following initial rejection earlier this year. The UK’s National Institute for Health and and Care Excellence (NICE) has recommended the use of Roche’s antibody ... With the updated information, the treatment
-
US states claim Purdue Pharma owes $2.2 trillion over opioid crisis
The states say the cost of the damages includes money for addiction treatment and health care, as well as lost revenue for business and child welfare and lost economic input of
-
Speed kills
recent interview: “There’s a cost to moving so quickly, however.
More from news
Approximately 9 fully matching, plus 2,914 partially matching documents found.
Latest Intelligence
-
Could formulary intelligence be your brand differentiator?
Sirdupla – a branded generic to Seretide (asthma), offering good cost savings for medicines management.
-
Route 66: can remote working put two-thirds of us back on the road to engaged employment?
All told, the most disengaged workers cost their employers 34% of their annual salary.
-
Exploiting the value of data in pharma
to accelerate drug discovery and efficacy testing while reducing time and cost to market. ... Time and cost to market. Through collaboration, pharmaceutical companies can reap the time and cost benefits of sharing information.
-
Has AI been the key to tackling the COVID-19 pandemic?
Earlier studies have suggested that AI can get new drugs to clinical trials five times faster, while bringing down industry costs by almost a third (30%).
-
AI: the smart money is on the smart thinking
Drug discovery. AI has the potential to significantly reduce the costs and time associated with drug discovery, across medical divisions and also specifically in handling the immediate COVID threat.
More from intelligence
Approximately 2 fully matching, plus 506 partially matching documents found.
Latest appointments
-
Merck appoints new chief information officer
He has a proven track record in successfully managing large-scale IT transformation initiatives, as well as building cost-effective international IT organisations.”.
-
Peter Kelly named managing director of Accord Healthcare UK
We remain committed to R&D and bringing cost competitive new products to market at the earliest opportunity.
-
IFPMA appoints Fumie Griego as assistant director general
and background in global affairs, including intellectual property protection, pricing, costs, value issues and health diplomacy.
-
Sandoz UK promotes Tim de Gavre to country head
As a market, the UK has one of the highest levels of generic use of any global market, and the NHS is also under severe cost pressures. ... Our combined portfolio of small molecule generics and biosimilars makes a significant different to medicines costs,
-
EY appoints global life sciences industry leader
New solutions will be required to meet the global challenges of sustainability of healthcare systems, aging populations, chronic disease and increasing cost pressures.
More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.
Latest from PMHub
-
OPEN VIE is awarded a Bronze Award at the PM Society Digital Awards 2020
The simplicity of the pathway shows the journey, costs and length of time to treatment thus highlighting the key issues that these patients go through on their journey to effective treatment.
-
Valid Insight: TRAVELLESS, the Virtual Workshop Solution for Pharma
Valid Insight’s virtual workshops can provide a cost-and-time effective solution, eliminating the challenges above, without any IT and technology concerns.
-
Enago Life Sciences
We focus our innovation on factors critical to our clients – reducing time to market, costs, whist improving engagement and quality.
-
If your clinical trial doesn’t have a website, do you even exist?
Just think about that for a moment. A clinical study can cost billions and take years to bring to fruition.
-
Site-related factors that can impact patient recruitment
Further, even though money is not an incentive for many patients, the cost of travel and reimbursement arrangements may also play a part.
More from PMHub
Approximately 3 fully matching, plus 370 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Lilly’s Verzenio scores a win in early-stage breast cancer
- Keytruda doubles five-year survival rate in NSCLC
- Live Webinar: Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- Live Webinar: Harnessing Technology to Improve Health and Healthcare
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Lilly’s Verzenio scores a win in early-stage breast cancer
- FDA sets January decision date for Xalkori in ALK-positive lymphoma
- Q&A: Isabel Gibson
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
